Login / Signup

In Search of a Gold Standard Patient-Reported Outcome Measure for Use in Chemotherapy- Induced Peripheral Neuropathy Clinical Trials.

Ellen M Lavoie SmithRobert KnoerlJames J YangGrace Kanzawa-LeeDeborah LeeCelia M Bridges
Published in: Cancer control : journal of the Moffitt Cancer Center (2018)
The sum-scored CIPN15 is reliable, valid, sensitive, and responsive when used to assess taxane- and platinum-induced CIPN.
Keyphrases
  • chemotherapy induced
  • patient reported outcomes
  • clinical trial
  • high glucose
  • diabetic rats
  • cancer therapy
  • drug induced
  • metastatic breast cancer
  • open label
  • silver nanoparticles
  • drug delivery
  • phase iii
  • double blind